Home Page - Reproductive Infectious Diseases Program

Faculty of MedicineReproductive Infectious Diseases Program | Department of Obstetrics & Gynaecology

The Reproductive Infectious Diseases Program is a network of health professionals, researchers and knowledge users dedicated to advancing reproductive infectious diseases care and research internationally. Through local, national and global research collaborations, the team works to address emergent knowledge gaps and provide evidence-based guidance for the prevention, treatment, and care of reproductive infectious diseases. An overview of the program and the research we do can be found here.

Latest Updates from the RID Program:

New Report Released from the RID Program’s CANCOVID-Preg Project!

The RID Program’s Canadian Surveillance of COVID-19 in Pregnancy: Epidemiology, Maternal and Infant Outcomes (CANCOVID-Preg) Project has just released a new report (Report #7) on some of the most recent updates, key findings and recommendations based on the latest data. This project has been led by Dr. Deborah Money and the rest of the RID Program team, as well as a team of national collaborators since April of 2020, to better understand the epidemiology and infant/maternal outcomes associated with COVID-19 infection in pregnancy.

For more information, Click here to access the report!

Register Now for the International Workshop on HIV & Women 2025!

Registration is now open for the 2025 iteration of the annual International Workshop on Women & HIV, which is being held from April 11-12, 2025 in Barcelona, Spain as well as virtually!

This workshop provides an exciting opportunity for experts in the research, treatment and care of women living with HIV from around the world, to meet and discuss the latest developments in the treatment and care of HIV in women and future areas of medical research.

Click here to get more information on the conference, and to register click here!

Check out our new syphilis resources!
The UBC Reproductive Infectious Diseases Program Team has recently launched a new set of resources to address the rising rates of syphilis in pregnancy and congenital syphilis. The team would like to acknowledge the incredible contributions of collaborators from the BC Association of Aboriginal Friendship Centres and Ahasiw Creative. Syphilis in Pregnancy Resource Maternal and Congenital […] Read More
REACT-Syph Project Team Attends the 2024 BC Provincial Perinatal Substance Use Conference to Distribute Resources on Congenital Syphilis and Syphilis in Pregnancy as Part of Ongoing Knowledge Mobilization Efforts!
RID Program team members Emma Karlsen and Roisin Delaney attended as exhibitors to help showcase the ongoing work of the RID Program's REACT-Syph (Towards the Eradication of Congenital Syphilis in Canada: Canadian Maternal and Congenital Syphilis Surveillance) Project Read More
New Report Released from the RID Program’s CANCOVID-Preg Project!
The RID Program's Canadian Surveillance of COVID-19 in Pregnancy: Epidemiology, Maternal and Infant Outcomes (CANCOVID-Preg) Project has just released a new report (Report #7) on some of the most recent updates, key findings and recommendations based on the latest data. Read More
New Publication: “Reliability and validation of an electronic penicillin allergy risk-assessment tool in a pregnant population” Accepted by Allergy, Asthma & Clinical Immunology!
A new publication from a team of authors that includes multiple members of the RID Program, including Dr. Chelsea Elwood, Dr. Julie van Schalkwyk, and Melissa Watt has been accepted by Allergy, Asthma, & Clinical Immunology and will be published in a future issue of the journal! Read More
New Publication: “Maternal-infant transfer of SARS-CoV-2 antibodies following vaccination in pregnancy: A prospective cohort study” published in Vaccine!
A new publication from the RID Program team on the findings of the COVERED Project's Immune Sub-Study has been published in Vaccine! Read More

Highlighted Research

NOVA-HIV

A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living with HIV

The goal of this study is to explore reduced dosing of the nonavalent HPV vaccine in women living with HIV. This multi-site phase IV clinical trial will carry on from our previous HPV in HIV studies. Recruitment began in late 2023 and is currently ongoing.

Antenatal Serostudies

Canadian Population Serological Survey Utilizing Antenatal Serum Samples

This national project will improve our understanding of the seroprevalence of antibodies to SARS-CoV-2 using antenatal blood samples which are routinely taken as part of prenatal care. Pregnant women are representative of generally healthy adults from ages 18-45 years from all socioeconomic and cultural backgrounds; use of these existing samples will provide a window into the generally healthy adult population of Canada as a whole.

RECOVERED: Vaccine Registry for 2024 Pregnancies

Respiratory Syncytial Virus (RSV) Vaccine and Monoclonal Antibody Treatment in Canadian Pregnant Individuals and their Infants (RECOVERED): An Evaluation of Acceptability, Safety, and Efficacy

The RECOVERED Project is a Canada-wide project being conducted by the UBC Reproductive Infectious Diseases Program and is investigating Respiratory Syncytial Virus (RSV) Vaccines in pregnancy. The RECOVERED project aims to broaden our understanding of vaccine attitudes, pregnancy outcomes, and infant outcomes related to maternal vaccination and infant monoclonal antibody treatment for RSV.